S. Moll

Discipline

Economies et finances (1)

Type de document

Co-auteur

S. Rotman

H. Hopfer

J.P. Venetz

M. Trendelenburg

V. Tesar

J. Steiger

H. Seeger

J. Schifferli

S. Schaub

C. Saganas

S. Sadallah

S. Regenass

E. Potlukova

M.L. Picazo

N. Perrottet

M. Pascual

G. NANCHEN

T. Muller

J. Martinez-Ara

O. Manuel

M. Lopez-Trascasa

E. Locher

M. Koller

A.D. Kistler

M.-J. Kim

E. Jancova

E. Honsova

B. Helmchen

K. Hadaya

D. Golshayan

V. Fremeaux-Bacchi

I. Fischer

M. Fernández-Ruiz

A. Faivre

A. Enzler-Tschudy

M. Diebold

M. Dickenmann

S. Dahdal

L. Buhler

P. Boide

I. Binet

V. Aubert

Date

Source

Serveur académique Lausannois (3)

Mot-clé

Patients (3) Patients (3) puits (2) risque (2) adulte (2) Treatment (2) Control (2) Swiss (2) Risk (2) Kidneys--Diseases (2) Immunoglobulins (2) Biopsy (2) Biopsy (2) cohorte (2) adulte (2) temps (durée) (1) test (1) recommandation (1) traitement (1) association (1) pathologie (1) modèle (1) information (1) infection (1) danger (1) effet (1) dose (1) maladie (1) rétombée atmosphérique (1) âge (1)

Documents écrit par S. Moll (3) | parle de S. Moll (1)

Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased.

M. Diebold et al.

Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.

N. Perrottet et al. (2021)

High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis

M. Trendelenburg et al. (2006)